Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Compazine, Buccastem M, Stemzine
Prochlorperazine is used for the management of nausea and vomiting; and psychotic disorders including schizophrenia and anxiety. Off label it is used for behavioral syndromes in dementia and psychosis/agitation related to Alzheimer's dementia.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Nausea | 35 | 7 |
|
|
|||
| Nausea and vomiting | 24 | 8 |
|
|
|
||
| Migraine headaches | 8 | 2 |
|
|
|||
| Dizziness | 6 | 1 |
|
||||
| Other | 5 | 1 |
|
||||
| Gastroparesis | 4 | 0 |
See all 77 patients currently taking Prochlorperazine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Prochlorperazine
| Fatigue | 1 | |
|---|---|---|
| Anxious mood | 1 | |
| Excess mucus | 1 | |
| Tremor in hands | 1 | |
| Sensitive gums | 1 | |
| Parkinson's symptoms worsened | 1 | |
| See all 9 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Prochlorperazine. See all 20 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 6 | ||
| Course of treatment ended | 6 | ||
| Doctor's advice | 5 | ||
| Side effects too severe | 4 | ||
| Did not seem to work | 2 | ||
| Personal research | 1 |
Adherence
Taking treatment as prescribed
Adherence of Prochlorperazine
Always |
15 | 63% |
|
|---|---|---|---|
Usually |
3 | 13% |
|
Sometimes |
3 | 13% |
|
Never |
3 | 13% |
|
Burden
Difficulty being on treatment
Burden of Prochlorperazine
Very |
1 | 4% |
|
|---|---|---|---|
Somewhat |
1 | 4% |
|
A little |
6 | 25% |
|
Not at all |
16 | 67% |
|
Cost
Paid out of pocket
Cost of Prochlorperazine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
11 | 100% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 27, 2012.